Resmed (RMD) Shares Outstanding (Weighted Average) (2009 - 2026)

Resmed (RMD) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $145.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 0.99% year-over-year to $145.3 million; the trailing twelve-month figure through Mar 2026 stood at $145.3 million (down 0.99% YoY), and the FY2025 full-year result was $146.7 million, changed 0.21% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $145.3 million, roughly flat from $145.8 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $147.1 million in Q4 2023 and bottomed at $145.3 million in Q1 2026.
• The 5-year median for Shares Outstanding (Weighted Average) is $146.8 million (2023), against an average of $146.6 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) climbed 0.65%; it then slipped 0.99% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $146.6 million in 2022, then climbed by 0.37% to $147.1 million in 2023, then slipped by 0.18% to $146.8 million in 2024, then slipped by 0.68% to $145.8 million in 2025, then fell by 0.34% to $145.3 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $145.3 million (Q1 2026), $145.8 million (Q4 2025), and $146.2 million (Q3 2025), per Business Quant data.

Peer Comparison